Cargando…
Molecular analysis in a GALNS study cohort of 15 Tunisian patients: description of a novel mutation
BACKGROUND: Mucopolysaccharidosis type IVA (MPS IVA) is an autosomal recessive disease caused by the deficiency of the lysosomal enzyme N-acetylgalactosamine-6-sulfate sulfatase (GALNS). The purpose of this study was to analyze the GALNS mutations and the haplotypes associated. METHODS: Mutation scr...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4912732/ https://www.ncbi.nlm.nih.gov/pubmed/27317439 http://dx.doi.org/10.1186/s13000-016-0498-y |
_version_ | 1782438313656844288 |
---|---|
author | Chkioua, Latifa Khedhiri, Souhir Hafsi, Hind Grissa, Oussama Ben Turkia, Hadhami Miled, Abdelhedi Laradi, Sandrine Froissart, Roseline Alif, Najat |
author_facet | Chkioua, Latifa Khedhiri, Souhir Hafsi, Hind Grissa, Oussama Ben Turkia, Hadhami Miled, Abdelhedi Laradi, Sandrine Froissart, Roseline Alif, Najat |
author_sort | Chkioua, Latifa |
collection | PubMed |
description | BACKGROUND: Mucopolysaccharidosis type IVA (MPS IVA) is an autosomal recessive disease caused by the deficiency of the lysosomal enzyme N-acetylgalactosamine-6-sulfate sulfatase (GALNS). The purpose of this study was to analyze the GALNS mutations and the haplotypes associated. METHODS: Mutation screening of the GALNS gene was performed by direct sequence analysis using DNA samples from 15 unrelated Tunisian MPS IVA patients. We also analyzed the haplotypes associated with the novel mutation and with the other reported GALNS mutations. RESULTS: We have identified an unreported missense mutation p.D288G (c.863A > G) in one patient, the most frequently c.120 + 1G > A (IVS1 + 1G > A) mutation in eleven MPS IVA patients and three previously reported mutations p.G66R, p.A85T and p.R386C on the other MPS IVA patients. All the studied patients were homozygous for these identified mutations. Bioinformatics analysis predicted the novel mutation as being probably pathogenic. These findings with the unobserved p.D288G mutation in controls subjects, suggested that it is a disease-causing mutation, which was correlated with the severe phenotype observed in the patients. We have found that the two GALNS unreported and reported mutations, respectively p.D288G and p.R386C, were associated with a common and specific haplotype. CONCLUSION: Our results were in agreement with previous reports from Tunisia, suggesting, on one hand the genotype/phenotype correlations in MPS IVA patients and the other hand the haplotype analyses were useful for determination of mutation origin in Tunisian population. |
format | Online Article Text |
id | pubmed-4912732 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-49127322016-06-19 Molecular analysis in a GALNS study cohort of 15 Tunisian patients: description of a novel mutation Chkioua, Latifa Khedhiri, Souhir Hafsi, Hind Grissa, Oussama Ben Turkia, Hadhami Miled, Abdelhedi Laradi, Sandrine Froissart, Roseline Alif, Najat Diagn Pathol Research BACKGROUND: Mucopolysaccharidosis type IVA (MPS IVA) is an autosomal recessive disease caused by the deficiency of the lysosomal enzyme N-acetylgalactosamine-6-sulfate sulfatase (GALNS). The purpose of this study was to analyze the GALNS mutations and the haplotypes associated. METHODS: Mutation screening of the GALNS gene was performed by direct sequence analysis using DNA samples from 15 unrelated Tunisian MPS IVA patients. We also analyzed the haplotypes associated with the novel mutation and with the other reported GALNS mutations. RESULTS: We have identified an unreported missense mutation p.D288G (c.863A > G) in one patient, the most frequently c.120 + 1G > A (IVS1 + 1G > A) mutation in eleven MPS IVA patients and three previously reported mutations p.G66R, p.A85T and p.R386C on the other MPS IVA patients. All the studied patients were homozygous for these identified mutations. Bioinformatics analysis predicted the novel mutation as being probably pathogenic. These findings with the unobserved p.D288G mutation in controls subjects, suggested that it is a disease-causing mutation, which was correlated with the severe phenotype observed in the patients. We have found that the two GALNS unreported and reported mutations, respectively p.D288G and p.R386C, were associated with a common and specific haplotype. CONCLUSION: Our results were in agreement with previous reports from Tunisia, suggesting, on one hand the genotype/phenotype correlations in MPS IVA patients and the other hand the haplotype analyses were useful for determination of mutation origin in Tunisian population. BioMed Central 2016-06-17 /pmc/articles/PMC4912732/ /pubmed/27317439 http://dx.doi.org/10.1186/s13000-016-0498-y Text en © The Author(s). 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Chkioua, Latifa Khedhiri, Souhir Hafsi, Hind Grissa, Oussama Ben Turkia, Hadhami Miled, Abdelhedi Laradi, Sandrine Froissart, Roseline Alif, Najat Molecular analysis in a GALNS study cohort of 15 Tunisian patients: description of a novel mutation |
title | Molecular analysis in a GALNS study cohort of 15 Tunisian patients: description of a novel mutation |
title_full | Molecular analysis in a GALNS study cohort of 15 Tunisian patients: description of a novel mutation |
title_fullStr | Molecular analysis in a GALNS study cohort of 15 Tunisian patients: description of a novel mutation |
title_full_unstemmed | Molecular analysis in a GALNS study cohort of 15 Tunisian patients: description of a novel mutation |
title_short | Molecular analysis in a GALNS study cohort of 15 Tunisian patients: description of a novel mutation |
title_sort | molecular analysis in a galns study cohort of 15 tunisian patients: description of a novel mutation |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4912732/ https://www.ncbi.nlm.nih.gov/pubmed/27317439 http://dx.doi.org/10.1186/s13000-016-0498-y |
work_keys_str_mv | AT chkioualatifa molecularanalysisinagalnsstudycohortof15tunisianpatientsdescriptionofanovelmutation AT khedhirisouhir molecularanalysisinagalnsstudycohortof15tunisianpatientsdescriptionofanovelmutation AT hafsihind molecularanalysisinagalnsstudycohortof15tunisianpatientsdescriptionofanovelmutation AT grissaoussama molecularanalysisinagalnsstudycohortof15tunisianpatientsdescriptionofanovelmutation AT benturkiahadhami molecularanalysisinagalnsstudycohortof15tunisianpatientsdescriptionofanovelmutation AT miledabdelhedi molecularanalysisinagalnsstudycohortof15tunisianpatientsdescriptionofanovelmutation AT laradisandrine molecularanalysisinagalnsstudycohortof15tunisianpatientsdescriptionofanovelmutation AT froissartroseline molecularanalysisinagalnsstudycohortof15tunisianpatientsdescriptionofanovelmutation AT alifnajat molecularanalysisinagalnsstudycohortof15tunisianpatientsdescriptionofanovelmutation |